_872578

HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-2NN6, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-ENSG00000123737, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000175, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000176, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005634, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005730, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005829, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0006364, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0006955, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0017091, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0030307, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0043928, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0071028, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0071035, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00029697, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00607722, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00654592, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00845426, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR001247, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR015847, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR020568, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-NP_001029366.1, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-NP_005024.2, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q12883, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q4W5P5, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q86Y41, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q86Y48, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-REACT_21257, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-REACT_71, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-EBI-347966, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-Q06265

Autoantigen PM/Scl 1, EXOSC9, Exosome component 9, P75 polymyositis-scleroderma overlap syndrome-associated autoantigen, PMSCL1, Polymyositis/scleroderma autoantigen 1, Polymyositis/scleroderma autoantigen 75 kDa

Exosome complex component RRP45